odiparcil

	odiparcil
Trade Name
Orphan Indication	Mucopolysaccharidosis type VI
USA Market Approval	USA
USA Designation Date	2017-08-03 00:00:00
Sponsor	Inventiva Pharma;50 rue de Dijon, Daix 21121;